Yanoc, Cherry Mae P.
HRN: 28-58-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CEFAZOLIN 1GM (VIAL)
02/24/2026
03/02/2026
IV
1g
Q8
S/P Oophorectomy
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: